Biomarker Discovery and Validation (Editorials) Biomarker Discovery and Validation (Editorials)

Biomarker Discovery and Validation (Editorials‪)‬

Clinical Chemistry, 2006, Sept, 52, 9

    • 2,99 €
    • 2,99 €

Publisher Description

Currently available biomarkers, such as those used to diagnose myocardial infarction (e.g., cardiac troponins), were identified in the course of targeted physiologic studies. Similarly, basic investigation of diseases has largely been characterized by studies of isolated molecules in cellular systems. Advances in genomics technologies, however, are beginning to permit characterization of global alterations associated with disease conditions and, in the process, identification of novel biomarkers and pathways. Laterza et al. (1) used such a global survey, and in this issue of Clinical Chemistry they describe their discovery of potential new markers related specifically to brain injury. Now begins the long road toward validation of these markers in clinically relevant human cohorts. Although no serum biomarkers of brain injury for conditions such as stroke are in clinical use, they could ultimately prove to be of enormous clinical usefulness to complement physical and radiologic examinations, both of which can be ambiguous during acute presentations. Of the multiple genomics applications, perhaps none has garnered more recent attention for biomarker discovery than proteomics. Proteomics offers unique insight into disease because proteins and their bioenzymatic functions largely determine the phenotypic diversity that can arise from a set of common genes. Posttranslational modifications help regulate structure, function, localization, maturation, and turnover of proteins. Because the entire complement of expressed proteins in their various forms can rapidly change in response to environmental cues, the proteome represents the unique ensemble of proteins that reflects the state of the cell or group of cells at a given time, in a particular context under particular stimuli. Thus, the proteome is highly dynamic, in contrast to the stability of the genome.

GENRE
Science & Nature
RELEASED
2006
1 September
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
155.4
KB
Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor) Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor)
2002
Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report) Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report)
2008
Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss (Molecular Diagnostics and Genetics) Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss (Molecular Diagnostics and Genetics)
2003
Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology) Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology)
2004
Metabolic, Nutritional, Iatrogenic, And Artifactual Sources of Urinary Organic Acids: A Comprehensive Table. Metabolic, Nutritional, Iatrogenic, And Artifactual Sources of Urinary Organic Acids: A Comprehensive Table.
2002
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997